10912 Professional Development courses delivered On Demand

Level 4 & 7 Endorsed Diploma | QLS Hard Copy Certificate Included | Plus 5 CPD Courses | Lifetime Access

Boost your career with Sales Psychology! Unlock proven strategies like silence, objection handling, and sincerity to skyrocket your closing rates. Enrol now!

A 505(b)(2) New Drug Application (NDA) is a submission to the Food and Drug Administration (FDA) for approval to market a drug in the USA. It differs from a ‘stand-alone’ NDA in that some of the data on which the applicant relies to demonstrate safety and efficacy have been obtained from publicly available sources rather than from the applicant’s own studies. The applicant typically proposes to market a drug that is based on an approved reference product but modified in its formulation or uses. A 505(b)(2) NDA also differs from an Abbreviated New Drug Application (ANDA) for approval of a generic drug in that the applicant’s product need not be a duplicate of the reference listed drug. The 505(b)(2) pathway may be said to lie part-way between the ‘stand-alone’ NDA and generics pathways, offering a unique combination of advantages to developers. It facilitates the modification of drugs to address unmet medical needs. The 505(b)(2) application pathway accounts for about half of all new drug approvals in the USA.

Use Delegation to Multiply your Effectiveness, Build Team Resilience, and Increase Motivation in your Team

How to Select and Apply the Right Leadership Style for Every Situation

A Practical Introduction to Change Management for Project Managers and Change Leaders

Project Definition Toolkit & How to Avoid Failure Bundled Together

How to Select and Apply the Right Leadership Style for Every Situation